TY  - CONF

T1  - PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN

JO  - Value in Health

PY  - 2019/11/01

AU  - Lindgren P

AU  - Hagström E

AU  - van Hout B

AU  - Villa G

AU  - Pemberton-Ross P

AU  - Arellano J

AU  - Sibartie M

AU  - Fonarow GC

ED  - 

DO  - DOI: 10.1016/j.jval.2019.09.765

PB  - Elsevier BV

VL  - 22

SP  - S548

EP  - S548

Y2  - 2024/10/22

ER  -